Relative risk of VTE, DVT, and PE according to calendar year, age, and sex.

<p>Relative risk of VTE, DVT, and PE according to calendar year, age, and sex.</p

Overall flow of analyses.

<p>Overall flow of analyses.</p

Annual incidence of VTE, DVT, and PE in the Korean population from 2009 to 2013.

<p>Annual incidence of VTE, DVT, and PE in the Korean population from 2009 to 2013.</p

Percentage of all VTE, DVT, and PE subjects who underwent procedures in each calendar year.

<p>Percentage of all VTE, DVT, and PE subjects who underwent procedures in each calendar year.</p

Pattern of prescription of anticoagulants during the study period.

<p>Pattern of prescription of anticoagulants during the study period.</p

The effects of <i>DROSHA</i> rs10719T>C variant on colorectal cancer (CRC) development modulated by diabetes mellitus (DM).

<p>Y-axis represents fold changes between <i>DROSHA</i> genotype TT+TC and <i>DROSHA</i> genotype CC. Each row represents the patients with or without DM. Each column represents <i>DROSHA</i> genotype TT+TC and <i>DROSHA</i> genotype CC.</p

Reported VTE incidence in studies conducted in the past decade.

<p>Reported VTE incidence in studies conducted in the past decade.</p

The combination of the polymorphisms of microRNA machinery genes in CRC patients and controls: male subgroup.

<p>^aAdjusted odds ratio on the basis of risk factors, such as age, gender, hypertension, diabetes mellitus.</p><p>^bFalse positive discovery rate (FDR)-adjusted <i>P</i>-value.</p><p>The combination of the polymorphisms of microRNA machinery genes in CRC patients and controls: male subgroup.</p

miRNA machinery gene genotype frequencies and AORs in colorectal cancer cases and controls.

<p>^aAdjusted odds ratio on the basis of risk factors, such as age, gender, hypertension, diabetes mellitus.</p><p>^bFalse positive discovery rate (FDR)-adjusted <i>P</i>-value.</p><p>miRNA machinery gene genotype frequencies and AORs in colorectal cancer cases and controls.</p

The combination of miRNA machinery genes polymorphisms based on MDR and CRC patients.

<p>^aAdjusted odds ratio on the basis of risk factors, such as age, gender, hypertension, diabetes mellitus. MDR, multifactor dimensional reduction.</p><p>^bFalse positive discovery rate (FDR)-adjusted <i>P</i>-value.</p><p>The combination of miRNA machinery genes polymorphisms based on MDR and CRC patients.</p